Navigation Links
Oxford BioMedica Announces Ocular Programme Update
Date:6/22/2011

plc (LSE: OXB) is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs.  The Company's technology platform includes a highly efficient LentiVector® gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy.  Through in-house and collaborative research, Oxford BioMedica has a broad pipeline and its partners include Sanofi, Sigma-Aldrich and Pfizer.  Further information is available at http://www.oxfordbiomedica.co.uk.

2. Oxford BioMedica's agreement with Sanofi

Under the terms of the agreement signed with Sanofi in April 2009, Oxford BioMedica is responsible for the pre-clinical and initial Phase I/II studies of four lentiviral vector-based product candidates in the field of ophthalmology: RetinoStat® for "wet" AMD, StarGen™ for Stargardt disease, UshStat® for Usher syndrome 1B and EncorStat® for corneal graft rejection.  Oxford BioMedica granted Sanofi a license to develop the products and an option for further development, manufacture and commercialisation on a worldwide basis.  At any time prior to or within a defined period after completion of each Phase I/II study, Sanofi can exercise its option to license the products and will then assume responsibility for on-going activities.  Sanofi also has rights to broaden its license to develop the four products in additional indications, and has rights of first refusal to license other lentiviral vector-based products for the treatment of ocular diseases.

3. LentiVector® gene delivery technology

Oxford Bio
'/>"/>

SOURCE Oxford Biomedica Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
2. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
3. ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology
4. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
5. Oxford Finance Corporation Hires Debbie Baker to Support Life Science Business Development in Western North America
6. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
7. Oxford Finance Corporation and United Orthopedic Group, Inc. Close $20 Million Credit Facility
8. Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
9. Oxford Finance Corporation Closes $25 Million Credit Facility with EUSA Pharma
10. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
11. Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Oct. 1, 2014 Ardelyx, Inc. ... biopharmaceutical company focused on cardio-renal, gastrointestinal and ... its 371 patient Phase 2b clinical trial ... bowel syndrome (IBS-C).  Results from this study ... in IBS-C symptoms for tenapanor-treated patients compared ...
(Date:10/1/2014)... Suisse, October 1, 2014 ... dans le domaine de l,analyse des données issues ... une solution de diagnostic in vitro (IVD) du ... complète de la mucoviscidose dans un seul essai ... caractériser tous les types de variantes par l,intermédiaire ...
(Date:9/30/2014)... health and safety of Canadians is our government,s highest priority.  Our ... at its disposal to help ensure that the drugs Canadians need ... end, Health Canada has taken decisive ... of all drug products from three plants in ... Pharmachem India Pvt Ltd , Apotex Research Private Limited ...
Breaking Medicine Technology:Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 2Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 3Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 4Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 5Ardelyx Reports Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients 6Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new ... retired couples. , Senior citizens can purchase a ... their loved ones. A joint policy is cheaper, but ... away. , Life insurance can be used to ... even be purchased online, as the application process is ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post ... for smokers. , Smoking will always have a negative ... the best method to find affordable coverage. Insurance brokerage ... coverage. , Whole life insurance premiums will be ... the coverage is permanent, the initial rates are ...
(Date:10/1/2014)... October 01, 2014 T.E.N., ... and relationship-marketing firm, announced today the nominees ... and Project of the Year Awards for ... representing organizations in financial services, commercial, health ... technology endeavors that address key issues in ...
(Date:10/1/2014)... A new genetic finding from Duke Medicine suggests ... and depression might also be hard-wired to gain weight ... heart disease. , An estimated 13 percent of people, ... susceptibility, and knowing this could help them reduce heart ... exercise and stress management. , "Genetic susceptibility, psychosocial stress ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Innovations announces ... scheduled to broadcast on Monday, October 20, 2014 at ... episode, Innovations will go behind the scenes to learn ... This segment will explore the practical help and information ... which teaches the warning signs of abuse, how to ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... Actress Sanaa Lathan Celebrates Inspirational Stories of how ... ENGLEWOOD CLIFFS, N.J., May 28 Skin is,amazing: it ... is a,symbol of pride, for others it,s a canvas to ... heritage to be honored. Skin means something different,to almost everyone ...
... SYK ) announced today that it will participate ... - 9:00 a.m. Eastern Time Seventh Annual Needham ... New York, New York, June 12, 2008 ... Annual Global Healthcare Conference Dana Point, California ...
... areas around the mouth and neck the sights in ... inevitable. They result from a structural breakdown inside the skin ... of new, youthful collagen, University of Michigan scientists say. ... and possible renewal, based on more than a decade of ...
... WASHINGTON, May 28 Legendary music producer,and ... for survivors,of the catastrophic earthquake that struck ... Myanmar. Jones recently recorded several public services,announcements ... now available to the,media ( http://www.redcross.org/QuincyJonesPSA )., ...
... protein MAEBL is critical for completing the life cycle ... transmit the potentially deadly infection to humans, a University ... ultimately help provide a way to better control malaria ... mosquito. , Researchers with the USF Global Health Infectious ...
... in the May 28, 2008 edition of The Journal ... action of certain brain cells altered by chronic alcohol ... the central amygdala, which plays an important role in ... alcohol drinking. In the study, alcohol-dependent rodents receiving gabapentin ...
Cached Medicine News:Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 2Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 3Health News:Vaseline(R) Cocoa Butter Campaign Uncovers Skin's Ability to Speak Volumes 4Health News:Stryker to Present at Investor Conferences 2Health News:Why some treatments rescue aging skin 2Health News:Why some treatments rescue aging skin 3Health News:Quincy Jones Lends Time and Talent to Support Red Cross Relief Efforts In China and Myanmar 2Health News:Protein plays key role in transmitting deadly malaria parasite 2Health News:Scripps Research scientists find seizure drug reverses cellular effects 2
... BrainSUITE iMRI is a neurosurgical OR ... and diagnostic tools, including iMRI, necessary ... BrainSUITE iMRI, neurosurgical treatments are performed ... and designed for MR compatibility and ...
... magnetic stimulator to offer the practical advantages ... designed to provide the simplest operation possible ... the same time, it may also help ... operations without moving away from your patient). ...
... The X-SIZER System ... catheter system for thrombus ... arteries and saphenous vein ... featuring,stainless steel cutter and,continuous ...
... Power, Deeper Lesions ,Designed for the ... Freezor MAX is a powerful ablation-only catheter. ... ablation tip was designed to provide maximum ... same cryoconsole as the other cryocatheters, but ...
Medicine Products: